COVID-19 Serological Point-of-Care
Results in 15 Minutes from a Simple Finger Stick
FDA Approved & American Made
COVID-19 serological point-of-care testing is for the detection of antibodies also known as IgM (immunoglobulinM) and IgG (immunoglobulinG). The ability to provide numerical results in 15 minutes can determine current or past exposure to the COVID-19 virus and monitoring infection progression.
The IgM & IgG test detects antibodies in the blood that are produced by the body in response to the Coronavirus infection. Numerical readings of the IgM & IgG antibodies have the ability to assist in determining people who exhibit mild to no symptoms.
Detection of an acute infection phase, as determined by the level of IgM antibodies, helps determine if a person may still be infectious and could possibly transmit the infection to other people. Further along in the infection progression, the body typically starts to produce IgG antibodies, which increase while the IgM levels decrease until eventually only IgG antibodies are present, demonstrating prior infection without the ability to transmit the virus.
Lynmar Health Management, Inc. is a local company and has provided various types of health screenings for over 30 years. We will be happy to help develop a COVID-19 antibody testing program for your organization. Please call Steven Beagle at 214-676-0643 for additional information about how this testing program may benefit your organization.